Transforming aging through health innovation

Bayer and NUS Enterprise (part of the National University of Singapore) will come together to foster and support innovative digital health technology in Singapore and across the Asia-Pacific region via the Bayer Grants4Apps Singapore Programme.

In this inaugural round of Grants4Apps Singapore, Bayer partners NUS Enterprise to launch an open innovation challenge in Singapore and across Asia Pacific which calls for innovative solutions to improve medication adherence in elders with chronic medical conditions.

See videos and media coverage on Grants4Apps Singapore launch here

Sign Up Now


Grants4Apps is a global web-based crowdsourcing initiative that was launched by Bayer in 2013, granting financial support to developers, start-ups and entrepreneurs. This enables them to develop their ideas for apps, hardware and software technology to improve health outcomes, pharmaceutical processes and generate better patient outcomes.

Winners of Grants4Apps Singapore may be admitted to the global Grants4Apps program and the Grants4Apps Accelerator and stand a chance to receive additional financial support up to 50,000 Euro, mentorships by Bayer managers and an international network of external entrepreneurs as well as coworking space at the global headquarters of Bayer Pharmaceuticals division in Berlin, Germany.

Why an open innovation challenge on medication adherence?

Asia is facing an aging crisis. This will pose a major healthcare challenge as well, as chronic diseases such as stroke, diabetes and eye diseases accompanying aging will likely rise.

While innovative medicines are being developed to manage these diseases, they would only work in people who take them. Medication adherence among the elderly population is a complex and multi-faceted issue, and Bayer would like to partner with stakeholders to discover solutions to address this public health challenge.

Grants4apps Singapore aims to bring together a diverse group of healthcare professionals, caregivers, scientists, engineers, students, programmers, developers, start-ups and entrepreneurs from across Asia Pacific. By pooling a wide range of perspectives and expertise, we hope to generate multidisciplinary ideas and develop innovative solutions to help people live longer, and lead healthier and more productive lives.


Bayer Grants4Apps® invites you to submit your innovative healthcare projects (not limited to apps). We are looking for novel software, hardware, technologies, or processes that can be applied on to particular areas contributing to improve health outcomes or pharmaceutical processes.


Send your proposal through the Grants4Apps website ( We are seeking projects that have commenced or are carefully thought-out.


Your submission will be reviewed by Bayer, together with representatives from university and hospital partners.


We will match shortlisted projects and teams with mentors from the university and industry. Selected teams will be mentored to develop their proposal and pitch.


Prize money

3 teams to receive $10,000 each


Bayer, NUS, industry partners


Incubation space with NUS Enterprise, in the heart of the innovation and entrepreneurship community


Access to broader network, pitch opportunities


For one team, air tickets to Berlin for the G4A event (tbc)



1 Dec 2016

Launch of the Call For Innovation

Dec 2016 to Mar 2017

Roadshows at Institute of Higher Learning and start-up communities

31 Mar 2017

Submission closed. Shortlisting takes place.

Early Apr onwards

Mentoring of selected teams (Bayer, NUS and complementary industry partners)

3-4 May 2017

Announcement of 3 selected teams @InnovFest unBound

May to Aug 2017

Incubation period for selected winning teams


For more information on the Grants4Apps challenge, check out this link


Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to

NUS Enterprise

NUS Enterprise plays a pivotal role in advancing innovation and entrepreneurship at NUS. It actively promotes entrepreneurship and cultivates global mind-sets and talents through the synergies of experiential entrepreneurial education, active industry partnerships, holistic entrepreneurship support and catalytic entrepreneurship outreach. As Asia’s Thought Leader for Innovation & Enterprise, its initiatives complement and add a unique perspective to NUS teaching and research at the University and beyond. For more information, visit


Is there a registration fee?

No registration fee

Who can apply?

This challenge is open to all teams in Asia Pacific (not limited to Singapore)

Do I own the intellectual rights to the submitted idea?

Yes. Please use the Submission Form on You only have to provide non-confidential information on your software, hardware, technology, or process, and answer a few questions about yourself. The submission must include a title, a detailed description of the problem you want to solve, your solution, and a high-level plausible project plan. Please do NOT submit proprietary or confidential information or source code.

Can I see projects submitted by other people?

No, not at the submission stage. We encourage you to attend our roadshow: we will be organising events at selected Institutes of Higher Learning, hospitals and startup communities. The goal is to bring together design, healthcare, business and technical professionals to learn about medication adherence via problem pitches that outline the pain points. Participants can then interact and compare interests, maybe even pitch solutions to one another and then form teams (if they are not yet in teams) to submit a proposal.

Can I submit more than one project?

Yes, however, please note we are seeking carefully thought through submissions or projects which have already started (and not just an idea).

Who are the persons in the evaluation panel that shortlist the teams for incubation?

The evaluation panel will include representatives from Bayer, NUS and other university and hospital partners.

What happens after I submit an idea?

The Bayer review team will respond to you within six to eight weeks after the submission end date. If your submission is selected for financial support, you will be given a contract to sign. Please read more about the terms and conditions within the submission form. The financial support is intended to help you develop and implement your proposed solution. After development, we will ask you to show the results. How your development and results are shown will be decided on a case by case basis. Failure to comply effectively with the contract may result in a termination of the proposed financial support. If your project is deemed relevant by Bayer, we may be interested in collaborating with you to help leverage the development of your application. This would entail the negotiation of a separate contract reflecting the interest of all parties involved.

When will I be notified if my team is selected?

Within six to eight weeks after the submission end date.

What are the next steps if my team is selected?

Your team will get mentoring from Bayer, NUS and complementary industry partners. There will be a pitching competition in May and we will award prizes to 3 winners.